Jaguar Health Inc. (NASDAQ: JAGX) Featured in Coverage of Benzinga’s Healthcare Small Cap Conference
Jaguar Health (NASDAQ: JAGX) is a commercial stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Their wholly owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary plant-based human gastrointestinal pharmaceuticals from plants harvested responsibly from rainforest areas. Their Mytesi(R) (crofelemer) product is approved by the U.S.…